KIORA PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Business
KIORA PHARMACEUTICALS, INC. (KPRX) reported Gain (Loss) on Disposition of Business of $0 for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-07-07.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfBusiness · last filed 2022-07-07
- KIORA PHARMACEUTICALS, INC. gain (loss) on disposition of business for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- KIORA PHARMACEUTICALS, INC. gain (loss) on disposition of business for fiscal 2020 was $113.72K.
| Period end | Gain (Loss) on Disposition of Business 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K/A · filed 2022-07-07 |
| 2020-12-31 | $113.72K 10-K/A · filed 2022-07-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |